Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope - Test2 - elhamkhani - TriplyDB

Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope

Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope

http://www.wikidata.org/entity/Q27674417

about

Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the host Development, characterization and application of monoclonal antibodies against Brazilian Dengue virus isolates Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity Dengue structure differs at the temperatures of its human and mosquito hosts Structural Changes in Dengue Virus When Exposed to a Temperature of 37 C A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface Identification of a New Broadly Cross-reactive Epitope within Domain III of the Duck Tembusu Virus E Protein Dengue: knowledge gaps, unmet needs, and research priorities A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis Innate immunity to dengue virus infection and subversion of antiviral responses.Combined effects of the structural heterogeneity and dynamics of flaviviruses on antibody recognition.Cross-reactivities between human IgMs and the four serotypes of dengue virus as probed with artificial homodimers of domain-III from the envelope proteins.The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein Direct and indirect interactions in the recognition between a cross-neutralizing antibody and the four serotypes of dengue virus.Dissection of antibody specificities induced by yellow fever vaccination Atomic-level functional model of dengue virus Envelope protein infectivity.The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.Detection of serotype-specific antibodies to the four dengue viruses using an immune complex binding (ICB) ELISA Potent dengue virus neutralization by a therapeutic antibody with low monovalent affinity requires bivalent engagement.Comprehensive mapping of functional epitopes on dengue virus glycoprotein E DIII for binding to broadly neutralizing antibodies 4E11 and 4E5A by phage display.Genotypic Differences in Dengue Virus Neutralization Are Explained by a Single Amino Acid Mutation That Modulates Virus Breathing.Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry Dengue virus antibody database: Systematically linking serotype-specificity with epitope mapping in dengue virus.A game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection.Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection.Epitope Identification and Application for Diagnosis of Duck Tembusu Virus Infections in Ducks.Conformational changes in intact dengue virus reveal serotype-specific expansion.B cell response and mechanisms of antibody protection to West Nile virus.Electron microscopy: essentials for viral structure, morphogenesis and rapid diagnosis.Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development.Enhancing dengue virus maturation using a stable furin over-expressing cell line Molecular basis of antibody-mediated neutralization and protection against flavivirus.Vaccines licensed and in clinical trials for the prevention of dengue.Complexity of Human Antibody Response to Dengue Virus: Implication for Vaccine Development.A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from disease A novel mechanism of antibody-mediated enhancement of flavivirus infection.Structural Basis of Zika Virus-Specific Antibody Protection.Molecular docking NS4B of DENV 1-4 with known bioactive phyto-chemicals.

P2860

Q23925011-A96272D6-8472-440D-9BF3-00064AF14E34 Q24288673-F21692D6-C13B-467B-8E51-B02522AB33E9 Q24289014-66970236-2AC3-423D-90CD-44B63013794A Q27654848-B8A8B28D-EB5E-42B5-A5BE-B39C401DA880 Q27677270-E2C98FE6-9A9C-4EC2-AE5E-1099C9E49693 Q27677962-F680B55D-B805-4066-8AA2-FE077760E054 Q27681319-D959160D-C1DA-497A-A8AF-CDD2D9D74CE3 Q27927982-0394A2F7-A631-4E14-B402-B547F915876E Q28729764-D35C12E0-B4FD-4738-8226-B40CFF64C5F5 Q28804076-379AEEAA-60EA-4310-8872-0B7DB2D44BD3 Q28804225-AE89AF4F-9483-48A5-AD9E-9B4E231C2D97 Q34240105-7A5BEF81-FE48-4B3D-87A0-48CCFA6E693B Q34261496-BDE81E64-B285-4FC6-B365-2AEFA8A3732F Q34354665-E0B71DAA-94CE-4A8F-A528-4DD062FFBEAA Q34386384-5C07F1F3-DAAD-4D73-8A0A-7F37C36F817C Q34408025-4F7B25C1-3565-4413-8DC9-CBE9588808E0 Q34789343-A134D17C-2D26-4A9F-9036-9616B74A9799 Q35026063-961AFEBD-9F3C-40D6-B1E5-A09964AC1F07 Q35069160-663F3AA5-CB1F-4DDF-BEBD-4ED8A9370C66 Q35081258-18044747-D5FD-4A83-A1DE-6DC8AAEFFA2B Q35152094-14BD7D87-BD77-45F8-BCE5-BA2F32948E10 Q35764445-3AF12BDA-21EB-4881-9186-E92AE9665EAB Q36245225-16775985-9F40-47F1-9D56-927E4B0B3188 Q36281127-35EC4328-713C-4DE9-82E3-A29246C3A6EA Q36286276-1077DEFF-58AE-4226-A819-5932847B7C8E Q37012203-C9B30CCF-1F00-4EBD-9AD8-C894F5B7B7F1 Q37123259-4E352A8C-5BF6-42CF-A6DC-153C5D308962 Q37450181-3C1B073A-69B5-4494-8B73-26DD1B16E156 Q37642687-2E815239-98B4-41B6-A535-659E7B8455C1 Q37673123-3FAC5C02-EE3E-4CE6-B7DE-FC3896AC6F09 Q38103193-A392015D-AC64-4268-88DB-071FB29C67A0 Q38636217-7A32EAEA-F9D6-4CA1-9CD8-82E13A8EEAB7 Q38758003-B69E9D31-411F-4986-93F4-1BF83141E395 Q38948606-FD9D6C3E-61B2-4C66-AEEA-35F18EB791F2 Q39172722-365F575E-9692-4EF8-8288-2528AC7AACDD Q39535403-BF04BBF1-9B20-4F68-A58B-F4A325A4C701 Q39811978-3D3C8207-DADB-4C5F-AE62-30076A48C894 Q40038769-E8411804-4CA9-486B-8740-7475D78C7979 Q40056291-A43A2236-21A5-4CED-B0A0-9E73AD4432C7 Q40070882-BFE0193F-7CB0-4DA7-BDB1-BBE87A85678D

P2860

Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope

http://www.wikidata.org/entity/Q27674417

description

2012 nî lūn-bûn

@nan

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Structural Basis of Differenti ...... t Recognizes a Cryptic Epitope

@ast

Structural Basis of Differenti ...... t Recognizes a Cryptic Epitope

@en

Structural Basis of Differenti ...... t Recognizes a Cryptic Epitope

@nl

type

label

Structural Basis of Differenti ...... t Recognizes a Cryptic Epitope

@ast

Structural Basis of Differenti ...... t Recognizes a Cryptic Epitope

@en

Structural Basis of Differenti ...... t Recognizes a Cryptic Epitope

@nl

prefLabel

Structural Basis of Differenti ...... t Recognizes a Cryptic Epitope

@ast

Structural Basis of Differenti ...... t Recognizes a Cryptic Epitope

@en

Structural Basis of Differenti ...... t Recognizes a Cryptic Epitope

@nl

P1433

Q27674417-B0767C20-D91F-4264-A3C6-54D1DF3E9E51

P1476

Q27674417-F97723D8-7CEE-4DC5-AD0B-B3CD40D4DD58

P2093

Q27674417-1A63CEAB-47F6-4D85-A9BF-C17166933670

Q27674417-6B05D252-0423-431B-A9F1-DD08EB5BB54F

Q27674417-7CADAEF9-5046-470F-BC6C-06A6FAB4F908

Q27674417-82780553-9A82-4101-AE01-164A24301FEB

Q27674417-9A701F3E-5A56-486A-855E-EFFDD87E404B

P2860

Q27674417-03ADB25B-F591-4BF9-A47C-0A33735C5ACD

Q27674417-0CC9A6C8-4A57-4995-BC29-5482A0D0C902

Q27674417-10305A5A-53A9-4238-A4E8-F69D2C7F1E56

Q27674417-1173F75E-5338-4C36-96CC-C4BB1EB1F8B6

Q27674417-1D0C7486-A0AB-4F77-B8CE-EEBD5D65905F

Q27674417-208F57C1-BFD8-4E56-A0FE-E77B2976CEB8

Q27674417-20E7AF9F-6C55-4CB3-A26F-82A3EDC633C2

Q27674417-22AE7F71-F3B6-4A0B-A649-EF417BA1A32A

Q27674417-22E754A1-0B6E-4425-9388-6CCBE5B26459

Q27674417-23A3ACF4-4A7F-4031-A897-B45721A426D5

P304

Q27674417-48D6DF9A-F3F2-432F-89FB-905E38BDF84E

P31

Q27674417-AF799521-C38F-46DD-8038-9D9DB3241D7E

P3181

Q27674417-ACF4F245-E1ED-4CFF-81C5-276E0A0A6971

P356

Q27674417-6BC7078C-1168-479A-80E0-51E1F0F1A2E2

P433

Q27674417-B7663512-A57F-4823-A392-6EFD4DF8F7D3

P478

Q27674417-6F42F784-0DCF-45CB-AC0F-3582C82FD4A2

P50

Q27674417-641B1E6B-FA9D-4428-BC8A-5C2ACE81211A

Q27674417-77F1F6F6-CD69-453A-9C33-91EAEDE31D57

Q27674417-C444B6AD-0013-4100-892A-FEC4E6D3F365

Q27674417-C53E08DE-2108-4631-A02F-7874E036B0D9

P577

Q27674417-82EB9D5F-D5CC-4E46-BD58-E4E8FD0FA544

P5875

Q27674417-AACB8C44-6AB7-4A4C-9224-79C22F84AE92

P698

Q27674417-92BF968E-B03C-4D58-87A0-78E0EF1F8E2E

P921

Q27674417-4A509831-F1F5-4524-9D62-3E2D74B26059

P932

Q27674417-DCECBF55-9970-49EC-92B1-1580A0748DBB

P3181

P356

JOURNAL.PPAT.1002930

P1433

P1476

Structural Basis of Differenti ...... t Recognizes a Cryptic Epitope

@en

P2093

Christopher A Nelson

http://www.w3.org/2001/XMLSchema#string

Daved H Fremont

http://www.w3.org/2001/XMLSchema#string

Melissa A Edeling

http://www.w3.org/2001/XMLSchema#string

S Kyle Austin

http://www.w3.org/2001/XMLSchema#string

Syd Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

PHENIX: a comprehensive Python-based system for macromolecular structure solution

Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody

Cryptic Properties of a Cluster of Dominant Flavivirus Cross-Reactive Antigenic Sites

A ligand-binding pocket in the dengue virus envelope glycoprotein

Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein

Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus

P304

e1002930

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2640139

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PPAT.1002930

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Michael S. Diamond

Theodore C Pierson

Kimberly A Dowd

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232232511

http://www.w3.org/2001/XMLSchema#string

P698

23055922

http://www.w3.org/2001/XMLSchema#string

P921

P932

3464233

http://www.w3.org/2001/XMLSchema#string